Wednesday, December 13, 2017
 
 
Company News: Page (1) of 1 - 05/18/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Amgen Submits Biologics License Application To The FDA For Erenumab
Erenumab is an Investigative Treatment Specifically Designed to Prevent MigraineOnly Molecule in Late-Stage Development to Directly Target the Calcitonin Gene-Related Peptide ReceptorAmgen and Novarti...
(May 18, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Sales,Sales,USA,IT (Information Technology),Security,Medicine,Disease,healthcare,Therapy,Technology,Surgery,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   IBN - Business ,   IBN - ProductivityApps ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines